Welcome to the ECCMID 2021 programme page. 
We inform you that times mentioned on the programme refer to Central European Summer Time (CEST). Please make sure to take this into account when planning your attendance to the event. 

Please find below the colour code:

• Orange: Educational Workshops, Meet-the-Expert Sessions
• Green: Integrated Symposia
• Light blue: Symposia
• Dark blue: Keynote Lectures
• Grey: Special Sessions
• Pink: Oral Sessions

previous daynext daytoday

• Day
• Week
• Timeline

12 July 2021

	12a. COVID-19 1. Viral infections 2. Bacterial infection 3. Antimicrobial resistance 4. Diagnostics 5. Antimicrobials & stewardship 6. Fungal infections 7. Parasites & international health 8. Infection prevention & control 9. Basic microbiology 10. Immunology & vaccinology 11. Special sessions & Other 12. COVID-19 13. Integrated sessions - 1
all day
08:00           09:00           10:00           11:00           12:00           13:00           14:00           15:00           16:00           17:00           18:00           19:00           20:00	2254 • Role of rapid testing in the elimination of viral hepatitis 1. Viral infection & disease 1-hour Symposium 1b. Viral hepatitis (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance) Role of rapid testing in the elimination of viral hepatitis 2382 • How to accurately diagnose bone and joint infections 2. Bacterial infection & disease Meet-the-Expert Session 2h. Other How to accurately diagnose bone and joint infections S79 • Resistance issues with Gram-negatives from Asia and Africa 3. Bacterial susceptibility & resistance 1-hour Mini Oral Flash Resistance issues with Gram-negatives from Asia and Africa S86 • Bioinformatic tools for microbiologists 4. Diagnostic bacteriology & general microbiology 1-hour Mini Oral Flash Bioinformatic tools for microbiologists 2406 • JOHAN WILLEM MOUTON MEMORIAL SESSION - Challenges in using PK/PD and TDM for dose optimisation 5. New antibacterial agents, PK/PD & Stewardship 1,5-hour Symposium 5b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring JOHAN WILLEM MOUTON MEMORIAL SESSION - Challenges in using PK/PD and TDM for dose optimisation 2187 • How to resolve a breakthrough fungal infection 6. Fungal infection & disease Meet-the-Expert Session 6c. Antifungal drugs & treatment (incl clinical trials) How to resolve a breakthrough fungal infection S18 • Intestinal parasitic infections 7. Parasitic diseases & international health 1-hour Oral Session Intestinal parasitic infections S92 • Tracking and preventing healthcare-associated infections 8. Healthcare-associated & nosocomial infections, infection control 1-hour ePoster Review Tracking and preventing healthcare-associated infections       S32 • Many faces of COVID-19 12. COVID-19 1-hour Oral Case Session Many faces of COVID-19                                                                                                                                                 S95 • What's new in viral hepatitis 1. Viral infection & disease 1-hour Oral Session What's new in viral hepatitis 2202 • Interactive paediatric cases for the clinical microbiologist and the adult physician 2. Bacterial infection & disease Meet-the-Expert Session 2h. Other Interactive paediatric cases for the clinical microbiologist and the adult physician S104 • Resistance to newer beta-lactam/inhibitor combinations 3. Bacterial susceptibility & resistance 1-hour Mini Oral Flash Resistance to newer beta-lactam/inhibitor combinations 2581 • Will metagenomic sequencing become a first line diagnostic tool? 4. Diagnostic bacteriology & general microbiology Meet-the-Expert Session 4h. Clinical metagenomics Will metagenomic sequencing become a first line diagnostic tool?   S122 • Rare fungal diseases 6. Fungal infection & disease 1-hour Oral Session Rare fungal diseases   S118 • Healthcare workers: COVID risk and protection 8. Healthcare-associated & nosocomial infections, infection control 1-hour Mini Oral Flash Healthcare workers: COVID risk and protection     S169 • Therapeutics Pipeline corner Therapeutics S7 • Advanced methods for SARS-CoV-2 detection and characterisation 12. COVID-19 1-hour Mini Oral Flash Advanced methods for SARS-CoV-2 detection and characterisation 2792 • The crucial role of rapid diagnostics in the early detection of secondary bacterial and fungal infections complicating COVID-19 11. Other 1-hour Integrated Symposium 11c. Other The crucial role of rapid diagnostics in the early detection of secondary bacterial and fungal infections complicating COVID-19                                                                                                                                                                         S168 • Global response to COVID-19: next steps 12. COVID-19 Keynote Lecture Global response to COVID-19: next steps S119 • Herpesviruses: continued challenges 1. Viral infection & disease 1,5-hour Oral Session Herpesviruses: continued challenges 2602 • Community-acquired respiratory tract infections: where do we stand in 2021 2. Bacterial infection & disease 1,5-hour Educational Workshop 2c. Community-acquired respiratory infections Community-acquired respiratory tract infections: where do we stand in 2021 S58 • Rapid detection of antibiotic resistance mechanisms 3. Bacterial susceptibility & resistance 1,5-hour Oral Session Rapid detection of antibiotic resistance mechanisms S107 • Molecular epidemiology of vaccine-preventable diseases 4. Diagnostic bacteriology & general microbiology 1,5-hour Oral Session Molecular epidemiology of vaccine-preventable diseases S16 • Impact of diagnostics on antimicrobial prescribing 5. New antibacterial agents, PK/PD & Stewardship 1-hour Oral Session Impact of diagnostics on antimicrobial prescribing S35 • New insights about Candida auris 6. Fungal infection & disease 1,5-hour Oral Session New insights about <em>Candida auris</em> 2350 • Hot topics in malaria 7. Parasitic diseases & international health 1,5-hour Symposium 7d. Parasitic disease epidemiology Hot topics in malaria 2299 • The evolving landscape of healthcare-associated infections: recent advances in prevention 8. Healthcare-associated & nosocomial infections, infection control 1,5-hour Educational Workshop 8e. Hospital epidemiology, transmission, surveillance & screening (incl. environment) The evolving landscape of healthcare-associated infections: recent advances in prevention 2349 • Pathways to chronicity: mechanisms and evolution of persistence 9. Experimental microbiology, microbial pathogenesis & biofilm 1,5-hour Symposium 9d. Experimental and cellular microbiology Pathways to chronicity: mechanisms and evolution of persistence     2779 • Benchmarking the treatment of COVID-19 in LMICs 12. COVID-19 1,5-hour Educational Workshop 12l. Other Benchmarking the treatment of COVID-19 in LMICs                                                                                                                                                                                                                                                                                                                                                                                                           S191 • LB: Interventions for improving COVID outcome 1,5-hour Oral Session LB: Interventions for improving COVID outcome   S52 • Mono- or dual-therapy in bloodstream infections? That is the question 2. Bacterial infection & disease 1-hour Oral Session Mono- or dual-therapy in bloodstream infections? That is the question 2426 • Antimicrobial susceptibility testing tomorrow 3. Bacterial susceptibility & resistance 1-hour Symposium 3c. Susceptibility testing methods (incl assay validation and comparative studies, excl TB) Antimicrobial susceptibility testing tomorrow 2316 • How we deal with respiratory samples from patients with cystic fibrosis in a clinical microbiology laboratory 4. Diagnostic bacteriology & general microbiology Meet-the-Expert Session 4j. Other How we deal with respiratory samples from patients with cystic fibrosis in a clinical microbiology laboratory 2549 • Beta-lactam/beta-lactamase inhibitor combinations 5. New antibacterial agents, PK/PD & Stewardship 1,5-hour Educational Workshop 5f. Other Beta-lactam/beta-lactamase inhibitor combinations S114 • Changing landscape of superficial and invasive mycoses 6. Fungal infection & disease 1-hour Mini Oral Flash Changing landscape of superficial and invasive mycoses   S127 • Clostridioides difficile infection: painting a picture of prediction and prevention 8. Healthcare-associated & nosocomial infections, infection control 1,5-hour Oral Session <em>Clostridioides difficile</em> infection: painting a picture of prediction and prevention     2780 • Clinical Grand Round 11. Other 2-hour Symposium 11c. Other Clinical Grand Round S13 • COVID-19 co-infections diagnosis and management 12. COVID-19 1-hour Oral Session COVID-19 co-infections diagnosis and management 2699 • Syndromic diagnostics: better timing and better insights to improve patient care in COVID-19 and beyond 11. Other 2-hour Integrated Symposium 11c. Other Syndromic diagnostics: better timing and better insights to improve patient care in COVID-19 and beyond                                                                                                                                                 S74 • Endocarditis and bacteraemia due to Gram-positive species 2. Bacterial infection & disease 1-hour ePoster Review Endocarditis and bacteraemia due to Gram-positive species S54 • Selection for AMR across ecological niches 3. Bacterial susceptibility & resistance 1-hour Oral Session Selection for AMR across ecological niches S15 • Methods for improving diagnostics and strain typing 4. Diagnostic bacteriology & general microbiology 1-hour ePoster Review Methods for improving diagnostics and strain typing   2182 • What do the genes tell us regarding fungal infections 6. Fungal infection & disease 1-hour Symposium 6a. Fungal disease epidemiology What do the genes tell us regarding fungal infections     2173 • Causal association between infection and neurodegenerative disorders? 9. Experimental microbiology, microbial pathogenesis & biofilm 1-hour Symposium 9a. Microbial pathogenesis & virulence Causal association between infection and neurodegenerative disorders?     S60 • COVID-19 evaluation studies and method comparison 12. COVID-19 30min ePoster Review COVID-19 evaluation studies and method comparison                                                                                   S63 • Overview of national and international COVID-19 cohorts 12. COVID-19 30min ePoster Review Overview of national and international COVID-19 cohorts                                                                                                                       2258 • Changing paradigms in the treatment of bacterial infections: shorter (intravenous) therapy is better? 2. Bacterial infection & disease 1,5-hour Symposium 2h. Other Changing paradigms in the treatment of bacterial infections: shorter (intravenous) therapy is better? S64 • Update on resistance in Gram-positive cocci 3. Bacterial susceptibility & resistance 1,5-hour Oral Session Update on resistance in Gram-positive cocci 2213 • Practical aspects of genomic-based surveillance 4. Diagnostic bacteriology & general microbiology 1,5-hour Educational Workshop 4f. Whole genome sequencing (diagnostic, typing) Practical aspects of genomic-based surveillance 2477 • Disarming pathogens: a new strategy for controlling bacterial infections 5. New antibacterial agents, PK/PD & Stewardship 1,5-hour Symposium 5a. Mechanisms of action, new compounds, preclinical data & pharmacology of antibacterial agents Disarming pathogens: a new strategy for controlling bacterial infections   S42 • Schistosomiasis and echinococcosis 7. Parasitic diseases & international health 1,5-hour Oral Session Schistosomiasis and echinococcosis S71 • Healthcare-associated infections and transmission dynamics of antibiotic-resistant bacteria 8. Healthcare-associated & nosocomial infections, infection control 1-hour Mini Oral Flash Healthcare-associated infections and transmission dynamics of antibiotic-resistant bacteria   2519 • Continued challenges related to vaccine-preventable diseases 10. Immunology & vaccinology 1,5-hour Symposium 10c. General vaccinology (incl. policy, social aspects) Continued challenges related to vaccine-preventable diseases 2578 • Publishing your research results in COVID times: take advice with the editors 11. Other 1,5-hour Symposium 11b. Publishing, ethics, other academic and professional affairs Publishing your research results in COVID times: take advice with the editors S38 • Clinical epidemiology of COVID-19 12. COVID-19 1,5-hour Oral Session Clinical epidemiology of COVID-19                                                                                                                 2707 • Enabling critical testing needs in clinical microbiology: innovative, random-access molecular diagnostic solutions to address pandemic and post-pandemic needs 11. Other 2-hour Integrated Symposium 11c. Other Enabling critical testing needs in clinical microbiology: innovative, random-access molecular diagnostic solutions to address pandemic and post-pandemic needs                                                                                                                                             S196 • LB: New data on safety and efficacy of COVID vaccination 1-hour Oral Session LB: New data on safety and efficacy of COVID vaccination 2219 • HIV in Europe: getting to zero 1. Viral infection & disease 1-hour Symposium 1a. HIV/AIDS (incl diagnostics & epidemiology, anti-retroviral drugs, vaccines, treatment & susceptibility/resistance) HIV in Europe: getting to zero 2658 • New drugs and new regimens for treating drug-resistant tuberculosis 2. Bacterial infection & disease Keynote Lecture 2a. Tuberculosis and other mycobacterial infections (incl antimycobacterial drugs, treatment & susceptibility/resistance, diagnostics & epidemiology) New drugs and new regimens for treating drug-resistant tuberculosis 2250 • How I treat highly resistant Gram-negative bacterial infections 3. Bacterial susceptibility & resistance Meet-the-Expert Session 3b. Resistance surveillance & epidemiology: Gram-negatives How I treat highly resistant Gram-negative bacterial infections S72 • Microbiological diagnostics: teaching old dogs new tricks 4. Diagnostic bacteriology & general microbiology 1-hour Mini Oral Flash Microbiological diagnostics: teaching old dogs new tricks 2313 • Can pharma companies contribute effectively to the stewardship of new antibiotics? 5. New antibacterial agents, PK/PD & Stewardship 1-hour Symposium 5f. Other Can pharma companies contribute effectively to the stewardship of new antibiotics? S121 • Fungal biomarkers: an update 6. Fungal infection & disease 1-hour Mini Oral Flash Fungal biomarkers: an update     2174 • New approaches for tackling chronic biofilm-related infections 9. Experimental microbiology, microbial pathogenesis & biofilm 1-hour Symposium 9a. Microbial pathogenesis & virulence New approaches for tackling chronic biofilm-related infections S14 • Advances in vaccinology beyond usual suspects 10. Immunology & vaccinology 1-hour Oral Session Advances in vaccinology beyond usual suspects 5010 • Publishing in clinical microbiology and infectious diseases: 5-10 years outlook 11. Other Open Forum Publishing in clinical microbiology and infectious diseases: 5-10 years outlook S46 • Rapid diagnostics and Point-of-Care testing in COVID-19 12. COVID-19 1-hour Oral Session Rapid diagnostics and Point-of-Care testing in COVID-19                                                                                                                                                                     S41 • Slamming COVID with poetry 11. Other Special Session 11c. Other Slamming COVID with poetry                                                                                                                                                   2170 • Hot topics in non-pandemic respiratory viral infections 1. Viral infection & disease 1,5-hour Symposium 1c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility / resistance) Hot topics in non-pandemic respiratory viral infections S97 • Community-acquired bacterial CNS infections 2. Bacterial infection & disease 1,5-hour Oral Session Community-acquired bacterial CNS infections S96 • Environmental spread of AMR 3. Bacterial susceptibility & resistance 1-hour Mini Oral Flash Environmental spread of AMR   S37 • Translational studies using preclinical PK/PD models 5. New antibacterial agents, PK/PD & Stewardship 1,5-hour Oral Session Translational studies using preclinical PK/PD models   2204 • Parasitology updates for non-specialists: things you should remember 7. Parasitic diseases & international health 1,5-hour Educational Workshop 7g. International & public health Parasitology updates for non-specialists: things you should remember   S84 • Host-pathogen dynamics during infection 9. Experimental microbiology, microbial pathogenesis & biofilm 1,5-hour Oral Session Host-pathogen dynamics during infection   2622 • Infection and neurology: the hidden hydra 11. Other 1,5-hour Symposium 11c. Other Infection and neurology: the hidden hydra 2722 • Antimicrobial Stewardship in COVID times: a challenge within a challenge 12. COVID-19 1,5-hour Symposium 12h. Infection control Antimicrobial Stewardship in COVID times: a challenge within a challenge                                                                                                                                                     S12 • One Health studies of AMR dissemination 3. Bacterial susceptibility & resistance 30min ePoster Review One Health studies of AMR dissemination

Please note that times mentioned on the programme refer to Central European Summer Time (CEST).